180 related articles for article (PubMed ID: 24832632)
1. From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go?
Pathak A; Ewen S; Fajadet J; Honton B; Mahfoud F; Marco J; Schlaich M; Schmieder R; Tsioufis K; Ukena C; Zeller T
EuroIntervention; 2014 May; 10(1):21-3. PubMed ID: 24832632
[No Abstract] [Full Text] [Related]
2. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system.
Kaiser L; Beister T; Wiese A; von Wedel J; Meincke F; Kreidel F; Busjahn A; Kuck KH; Bergmann MW
EuroIntervention; 2014 May; 10(1):157-65. PubMed ID: 24472799
[TBL] [Abstract][Full Text] [Related]
3. [Renal artery denervation for treating refractory hypertension].
Benamer H; Louvard Y; Garot P; Unterseeh T; Hovasse T; Lefèvre T; Chevalier B; Morice MC
Ann Cardiol Angeiol (Paris); 2011 Dec; 60(6):354-60. PubMed ID: 22040858
[TBL] [Abstract][Full Text] [Related]
4. New analysis of the SYMPLICITY HTN-3 trial.
Mason E; Tofield A
Eur Heart J; 2015 Mar; 36(9):535. PubMed ID: 25884066
[No Abstract] [Full Text] [Related]
5. Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials.
Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
Blood Press; 2014 Jun; 23(3):135-7. PubMed ID: 24842262
[No Abstract] [Full Text] [Related]
6. Renal denervation in challenging anatomy: Current strategies and pre-procedural imaging.
Seewöster T; Hilbert S; Rogge C; Paetsch I; Jahnke C; Hindricks G; Bollmann A
Int J Cardiol; 2016 Dec; 224():1-3. PubMed ID: 27592066
[No Abstract] [Full Text] [Related]
7. Resistant hypertension and renal denervation. Considerations on the results of the SYMPLICITY HTN-3 trial.
Ruilope LM; Arribas F
Rev Esp Cardiol (Engl Ed); 2014 Nov; 67(11):881-2. PubMed ID: 25242659
[No Abstract] [Full Text] [Related]
8. Sympathetic renal denervation: hypertension beyond SYMPLICITY.
Barbash IM; Waksman R
Cardiovasc Revasc Med; 2013; 14(4):229-35. PubMed ID: 23928314
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous renal sympathetic denervation: 2013 and beyond.
Froeschl M; Hadziomerovic A; Ruzicka M
Can J Cardiol; 2014 Jan; 30(1):64-74. PubMed ID: 24365191
[TBL] [Abstract][Full Text] [Related]
10. SPYRAL HTN-OFF MED study: Renal denervation in the spiral orbits of current results and future studies.
Tsioufis C; Dimitriadis K; Papademetriou V; Tousoulis D
Hellenic J Cardiol; 2017; 58(5):320-321. PubMed ID: 29056558
[No Abstract] [Full Text] [Related]
11. Second denervation in a patient with resistant hypertension.
Prado JC; Salado D; Ruilope LM; Segura J
Clin Res Cardiol; 2016 Oct; 105(10):880-3. PubMed ID: 27278635
[No Abstract] [Full Text] [Related]
12. Renal artery denervation for the treatment of resistant hypertension. Update after Medtronic announcement that its Symplicity HTN3 study failed to meet its primary efficacy end point.
Sapoval M; Azizi M
Diagn Interv Imaging; 2014 Apr; 95(4):353-4. PubMed ID: 24656652
[No Abstract] [Full Text] [Related]
13. Blood pressure lowering effect of renal sympathetic denervation or placebo? - building expectations for Symplicity-HTN 3.
Kjeldsen SE; Narkiewicz K; Oparil S; Hedner T
Blood Press; 2013 Oct; 22(5):279-81. PubMed ID: 24059787
[No Abstract] [Full Text] [Related]
14. Renal denervation more successful when it includes accessory arteries.
Eur Heart J; 2015 Mar; 36(9):536. PubMed ID: 25884067
[No Abstract] [Full Text] [Related]
15. Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial.
Yerasi C; Baker NC; Jonnalagadda AK; Torguson R; Singh S; Vies J; Waksman R
J Am Soc Hypertens; 2015 Dec; 9(12):959-65. PubMed ID: 26687550
[TBL] [Abstract][Full Text] [Related]
16. Was there real denervation in the SYMPLICITY HTN-3 trial?
Ruilope LM
Eur Heart J; 2014 Jul; 35(26):1699-1700. PubMed ID: 25152949
[No Abstract] [Full Text] [Related]
17. Effect of unilateral catheter-based renal sympathetic denervation in a patient with resistant hypertension.
Kostka-Jeziorny K; Radziemski A; Tykarski A; Niklas A; Grajek S
Kardiol Pol; 2015; 73(2):132. PubMed ID: 25706782
[No Abstract] [Full Text] [Related]
18. [Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology].
Vonend O; Böhm M; Eckert S; Hausberg M; Rittger H; Rump LC; Schmieder R; Schulte KL; Schunkert H; Uder M; Veelken R; Vorwerk D; Weil J; Wenzel U; Mahfoud F
Dtsch Med Wochenschr; 2015 Mar; 140(5):363. PubMed ID: 25734680
[TBL] [Abstract][Full Text] [Related]
19. Renal Denervation: Is It Ready for Prime Time?
Lauder L; Wolf MA; Scholz SS; Hohl M; Mahfoud F; Böhm M
Curr Cardiol Rep; 2019 Jul; 21(8):80. PubMed ID: 31278490
[TBL] [Abstract][Full Text] [Related]
20. An update on renal artery denervation and its clinical impact on hypertensive disease.
Bhat A; Kuang YM; Gan GC; Burgess D; Denniss AR
Biomed Res Int; 2015; 2015():607079. PubMed ID: 26495305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
